Back to Results
First PageMeta Content
H2AFX / Biodosimetry / Ataxia telangiectasia mutated


Present and future clinical applications for gamma-H2AX Christophe E. Redon Laboratory of Molecular Pharmacology National Cancer Institute, NIH
Add to Reading List

Open Document

File Size: 4,25 MB

Share Result on Facebook

Company

gamma-H2AX Christophe E. Redon Laboratory / /

Facility

clinic DRUG THERAPY IRRADIATION ~1% Hairs ~1% ~1% Oral / clinic DSB / H2AX Christophe E. Redon Laboratory of Molecular Pharmacology National Cancer Institute / /

IndustryTerm

Present and future clinical applications / /

MedicalCondition

CTCs Tumor INVASIVE / /

MedicalTreatment

DRUG THERAPY / Radiation / chemotherapy / /

Organization

National Institute of Health / Molecular Pharmacology National Cancer Institute / /

Product

Screenings / Diagnostics Drug / Biodosimetry Screenings / Diagnostics Drug / /

Technology

Radiation / Drug development / chemotherapy / /

SocialTag